Your session is about to expire
← Back to Search
APOL1 Genetic Testing for Kidney Disease
N/A
Recruiting
Led By Elisa J Gordon
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Cognitively intact individuals
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately day 60
Awards & highlights
Study Summary
This trial is studying how well a chatbot-based program works in informing African American adults about their risk for kidney disease if they donate a kidney.
Who is the study for?
This trial is for cognitively intact, English-speaking adults of African descent, including a wide range of nationalities like African American/Black, Jamaican, and others who are considering becoming living kidney donors. It's not for those without African ancestry or pregnant women.Check my eligibility
What is being tested?
The study tests a culturally adapted APOL1 genetic testing program with components like genetic counseling and EHR integration. It uses the 'Gia' chatbot to help potential donors understand their risks and make informed decisions about donation.See study design
What are the potential side effects?
Since this trial involves genetic testing and counseling rather than medication or invasive procedures, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from learning about their genetic risks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am mentally sharp and can make decisions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately day 60
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately day 60
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Decisional Conflict Scale (DCS)
Secondary outcome measures
Preparation for Decision Making Scale (PDMS) Scores range from: Higher scores reflect greater preparation for decision making (a better outcome)
Satisfaction with the Informed Consent Process
Willingness to Donate Scores range from: 0 to 10. Higher scores reflect greater willingness to donate.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment3 Interventions
APOL1 testing program
Group II: Control ArmActive Control1 Intervention
No intervention will be administered. Usual care will be administered.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,861 Total Patients Enrolled
Georgetown UniversityOTHER
343 Previous Clinical Trials
136,112 Total Patients Enrolled
Elisa J GordonPrincipal InvestigatorNorthwestern University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am mentally sharp and can make decisions.I am 18 years old or older.My gender does not affect my eligibility.People who want to donate a kidney, whether to a specific person or to anyone in need.People with specific ethnic backgrounds and African ancestry are not eligible to be living kidney donors.
Research Study Groups:
This trial has the following groups:- Group 1: Control Arm
- Group 2: Intervention Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this investigation open at present?
"Clinicaltrials.gov records that this clinical trial was published on the 9th of September 2021 and recently updated on the 18th of November 2021, demonstrating current recruitment activity for prospective participants."
Answered by AI
What is the scale of participants in this research endeavor?
"Affirmative. Clinicaltrials.gov confirms that this experiment, which was first disseminated on September 9th 2021, is actively looking for participants. A total of 390 volunteers are required at two distinct locations."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger